Navigation Links
Derma Sciences Announces Several Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming APWCA Conference
Date:2/20/2008

"Utilizing Leptospermum Honey Alginate in Treatment of Recalcitrant Lower Extremity Ulcers", Dr. Steven J. Kavros, DPM, Mayo Clinic, Rochester, MN.

In addition to these presentations, the first topic on the conference's general session agenda following the keynote address will be "MEDIHONEY(TM): An Update on the Newly Approved Natural Approach to Chronic Wounds", to be presented by Dr. Robert Frykberg, DPM, FAPWCA, MPH, Chief of Podiatry, Carl T. Hayden VA Medical Center in Phoenix, AZ. In this session Dr. Frykberg will be providing an update on his continuing case series related to the treatment of recalcitrant diabetic foot ulcers with MEDIHONEY(TM) dressings, first presented at the Clinical Symposium on Advances in Skin and Wound Care last October.

MEDIHONEY is the first FDA-cleared honey-based dressing for use on chronic wounds and burns, and is the only FDA-cleared honey-based product currently commercialized. Its key ingredient, Active Leptospermum Honey, has been shown to be effective in a variety of wounds and burns, and was recently the focus of two positive large scale randomized controlled studies on leg ulcers. After four months on the market, the company has made the decision to expand its sales force to meet the high demand for this unique wound care device.

About Derma Sciences

Derma Sciences is a manufacturer and marketer of advanced wound-care products, with operations based in the US and Canada, and sales worldwide. The company recently launched its MEDIHONEY(TM) Wound & Burn dressings with Active Leptospermum Honey. The Company has also obtained FDA clearance to market and sell its MOBILITY-1(TM) boot and compressor device for the treatment of venous ulcers, lymphedema, and other conditions that require compression therapy. For more information about Derma Sciences, Inc., visit its home page on the Internet at http://www.dermasciences.com.

About the
'/>"/>

SOURCE Derma Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. 1st EMEA application filed for product using innovative intradermal microinjection system BD Soluvia
2. PriCara(TM) Recalls 25 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
3. NeoStrata Clinical Findings Reveal Benefits of Combining Glycolic Acid Peels and Targeted Home Care With Microdermabrasion for Optimized Treatment of Photodamaged Skin
4. AGI Dermatics Data Indicates 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1, Increases Collagen and Enhances DNA Repair
5. Leading Cosmetic Dermatologist, Peter G. Ballas II MD, Retains Kay Renz Public Relations to Promote his Practice and New Skincare Line
6. Prominent Cosmetic Dermatologist and Author Joins MySkinCareConnection.com
7. Dr. Neil Sadick Presents on Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
8. LOreal USA Announces Three-Year Support of Womens Dermatologic Society Foundation Community Outreach
9. Senetek PLC Announces Debut of Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
10. American Academy of Dermatology Caught in Pay-for-Play Scandal
11. New Technology and Improved Techniques Arm Dermatologists With Tools to Minimize Facial Scars From Skin Cancer Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... TN: MedixSafe has retracted a previous announcement from ... named Guardian 2. The correct product name is ... that significantly increases the complexity of security credentials. ... provides fast and easy access for both the ... with Vanguard technology tracks inventory by time, ...
(Date:2/28/2015)... 28, 2015 My Shiney Hiney® LLC., the ... team to Las Vegas, Nevada for the annual ASD Market ... of the leading consumer-goods tradeshows and My Shiney Hiney will ... event. My Shiney Hiney can be found at booth number ... for the at-home personal hygiene brush and cleansing system exclusively ...
(Date:2/27/2015)... Sacramento, Calif. (PRWEB) February 27, 2015 ... of liver-disease death, between four and 12 years earlier ... study from UC Davis Health System. , While previous ... ALD than other populations, the new study -- published ... -- is believed to be the first to pinpoint ...
(Date:2/27/2015)... Clara, CA (PRWEB) February 27, 2015 ... Passive Devices (IPD), has introduced miniature, wire bondable, silicon ... and Power LED markets. The ESD88NP ... transient currents away from sensitive LED and IC products. ... to Multilayer Varistors (MLV). All devices meet the ...
(Date:2/27/2015)... 2015 Just a little over two ... suffering from Sjögren’s Syndrome after a new autoantibody associated ... the University of Buffalo and Immco Diagnostics, Inc. After ... to develop a new diagnostic test that ... new autoantibodies. Researchers aimed to develop a test that ...
Breaking Medicine News(10 mins):Health News:New Name Announced For Newest MedixSafe Readers – MedixSafe Vanguard 2Health News:My Shiney Hiney® to Participate in ASD Market Week 2015 2Health News:UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 3Health News:Breakthrough Blood Test for Early Detection of Sjögren’s Syndrome Now Available 2
... , , Recognize Excellence in Reporting, Portrayals ... 31 , ALEXANDRIA, Va. , Feb. ... professionals to submit national, state, local and student news and ... the 2010 Media Awards. , Details, including categories and a ...
... , , TUCSON, Ariz. , Feb. 9 ... largest companies with over 11,000 employees nationwide, today announced that it ... , Providence , working with Peach Properties, will take over ... to the new site of Tucson Electric Power,s new headquarters. , ...
... ... extensive smile gallery and other resources and tools for patients , ... New York, NY (PRWEB) February 9, 2010 -- Leading ... the launch of its new Web site, www.SmileInTheCity.com . The site boasts simple navigation, ...
... biopsies done in doctor,s office boosted overall spending, study ... Medicare sweetened payments for simple office-based endoscopic procedures, doctors ... in-office bladder biopsies, but the volume of hospital procedures ... So, instead of saving money, Medicare expenditures rose 50 ...
... Feb. 9 Quantum Health, the Columbus, ... appointed Jim Stark to be Executive Vice President ... Director for Aon Consulting, will oversee Quantum Health,s national sales ... various Blue Cross/Blue Shield plans, national insurance carriers and third ...
... ... their teens a gift of knowledge and empowerment, because when romance heats up, teens often ... ... having ,The Talk, is probably one of the most difficult and challenging moments of parenthood. ...
Cached Medicine News:Health News:Mental Health America Encourages Journalists, Media Professionals to Submit Entries for 2010 Media Awards 2Health News:Mental Health America Encourages Journalists, Media Professionals to Submit Entries for 2010 Media Awards 3Health News:Providence Service Corporation Relocates Corporate Headquarters to Downtown Tucson 2Health News:Providence Service Corporation Relocates Corporate Headquarters to Downtown Tucson 3Health News:Top New York Dentists at Smile in the City Launch New Web Site 2Health News:Medicare Cost-Saving Moves Can Backfire 2Health News:Medicare Cost-Saving Moves Can Backfire 3Health News:Quantum Health Appoints Stark as Executive Vice President of Sales 2Health News:Don't Be a Sex Ed Horror Story — Keep the VD Out of Valentine's Day 2Health News:Don't Be a Sex Ed Horror Story — Keep the VD Out of Valentine's Day 3
(Date:2/27/2015)... Feb. 27, 2015 An aggressive campaign to ... the rate of infection with a dangerous drug-resistant bacteria ... Clostridium difficile, or C.diff, is a bacterium that ... of the colon. A recent article in the New ... Infection in the United States " ...
(Date:2/27/2015)... --  Synageva BioPharma Corp. (Synageva) (NASDAQ: ... products for rare diseases, joins the National Organization ... Rare Diseases™ (EURORDIS™), The Global Genes Project™, and ... Day. On the last day of ... participants conduct special events to raise awareness and ...
(Date:2/27/2015)... 27, 2015  PTC Therapeutics, Inc. (NASDAQ: ... financial results for the fourth quarter and full year ... a transformative year for PTC. We are now a ... RNA-targeted therapies in the rare disease space," stated Stuart ... "We are proud to bring the first treatment for ...
Breaking Medicine Technology:Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11
... Biotech, Inc. is pleased to,announce that it ... (PCT) patent from Australia, China and India. ... their Method of use for Gut-based,Therapy," protects ... oral,probiotic product formulation (Kibow Biotics(R)) which may ...
... Therapies Shows Similar, Sustained Response Rates; Fewer Patients ... ... KENILWORTH, N.J., Jan. 14 Schering-Plough,Corporation (NYSE: SGP ... of the IDEAL study, the first large, randomized, clinical,study comparing ...
Cached Medicine Technology:Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure 2Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure 3Schering-Plough Reports Top-Line Results of the IDEAL Study 2Schering-Plough Reports Top-Line Results of the IDEAL Study 3Schering-Plough Reports Top-Line Results of the IDEAL Study 4Schering-Plough Reports Top-Line Results of the IDEAL Study 5Schering-Plough Reports Top-Line Results of the IDEAL Study 6Schering-Plough Reports Top-Line Results of the IDEAL Study 7Schering-Plough Reports Top-Line Results of the IDEAL Study 8Schering-Plough Reports Top-Line Results of the IDEAL Study 9
Thermal Seal, Clear, Bulk...
Mylar Plate Sealers 100/Box...
OptiTape - Optically Clear sealing tape for OmniUltra PCR plates plus universal dispenser. 250 sheets....
The Heat Sealing Foil and Heat...
Medicine Products: